Tech Company Financing Transactions
Selexys Pharmaceuticals Funding Round
Selexys Pharmaceuticals closed a $2.8 million venture capital round on 4/20/2011. Backers included private investors.
Transaction Overview
Company Name
Announced On
4/20/2011
Transaction Type
Debt
Amount
$2,800,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. Includes a $1,000,000 Overallotment Option exercisable in the sole discretion of Selexys. Although the offering period has ended, Selexys has retained the right to reopen the offering for up to 90 days in certain circumstances. SEC regulatory filing.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
840 Research Parkway 510
Oklahoma City, OK 73104
USA
Oklahoma City, OK 73104
USA
Phone
Website
Email Address
Overview
Selexys Pharmaceuticals Corporation (Selexys) is a privately held company that is developing drugs to treat inflammatory and thrombotic diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Scott Rollins
Chief Medical Officer
Rodger McEver
Chief Scientific Officer
Richard Cummings
VP - Bus. Development
David Falconer
VP - Operations
Richard Alvarez
Browse more venture capital transactions:
Prev: 4/20/2011: bluebird bio venture capital transaction
Next: 4/20/2011: ex.fm venture capital transaction
Share this article
About Our VC Transactions Data
We report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs